This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)

From Oxford Club | Ad

Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.

>>>

TXG Insider Trading (10x Genomics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $90,614,346.75

10x Genomics Insider Trading History Chart

10x Genomics Share Price & Price History

^$47.63

▲ +6.71 (16.40%)

As of 05/13/2022 05:00 PM ET

Days: 30 | 90 | 365

The Last Great Value Stock

From Oxford Club | Ad

Last year it was more profitable than Disney, Square or even Tesla. But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.

>>>

10x Genomics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/22/2022	Benjamin J. Hindson	Insider	Sell	360	$78.59	$28,292.40
2/22/2022	Justin J Mcanear	CFO	Sell	288	$78.60	$22,636.80
2/22/2022	Serge Saxonov	CEO	Sell	551	$78.60	$43,308.60
2/15/2022	Bradford Crutchfield	Insider	Sell	17,000	$95.13	$1,617,210.00
2/8/2022	Serge Saxonov	CEO	Sell	12,000	$89.90	$1,078,800.00
1/12/2022	Bradford Crutchfield	Insider	Sell	17,000	$119.00	$2,023,000.00
1/4/2022	Serge Saxonov	CEO	Sell	15,000	$141.33	$2,119,950.00
1/3/2022	Benjamin J. Hindson	Insider	Sell	41,666	$146.08	$6,086,569.28
1/3/2022	Justin J Mcanear	CFO	Sell	10,000	$146.07	$1,460,700.00
12/13/2021	Bradford Crutchfield	Insider	Sell	17,000	$139.36	$2,369,120.00
12/7/2021	Serge Saxonov	CEO	Sell	15,000	$145.97	$2,189,550.00
12/1/2021	Benjamin J. Hindson	Insider	Sell	41,666	$148.08	$6,169,901.28
12/1/2021	John R. Stuelpnagel	Director	Sell	5,000	$151.16	$755,800.00
12/1/2021	Justin J Mcanear	CFO	Sell	10,000	$147.75	$1,477,500.00
11/24/2021	Sridhar Kosaraju	Director	Sell	1,500	$150.06	$225,090.00
11/22/2021	Benjamin J. Hindson	Insider	Sell	351	$148.38	$52,081.38
11/22/2021	Justin J Mcanear	CFO	Sell	281	$148.38	$41,694.78
11/22/2021	Serge Saxonov	CEO	Sell	772	$148.38	$114,549.36
11/16/2021	John R. Stuelpnagel	Director	Sell	5,000	$158.83	$794,150.00
11/12/2021	Bradford Crutchfield	Insider	Sell	17,000	$164.92	$2,803,640.00
11/2/2021	Serge Saxonov	CEO	Sell	15,000	$161.25	$2,418,750.00
11/1/2021	Benjamin J. Hindson	Insider	Sell	41,666	$163.58	$6,815,724.28
11/1/2021	John R. Stuelpnagel	Director	Sell	5,000	$163.51	$817,550.00
11/1/2021	Justin J Mcanear	CFO	Sell	10,000	$163.54	$1,635,400.00
10/25/2021	Sridhar Kosaraju	Director	Sell	1,500	$166.32	$249,480.00
10/18/2021	John R. Stuelpnagel	Director	Sell	5,000	$150.67	$753,350.00
10/12/2021	Bradford Crutchfield	Insider	Sell	17,000	$157.30	$2,674,100.00
10/5/2021	Serge Saxonov	CEO	Sell	15,000	$143.50	$2,152,500.00
10/1/2021	Benjamin J. Hindson	Insider	Sell	41,666	$143.56	$5,981,570.96
10/1/2021	Justin J Mcanear	CFO	Sell	10,000	$143.52	$1,435,200.00
9/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$159.04	$238,560.00
9/16/2021	John R. Stuelpnagel	Director	Sell	5,000	$156.33	$781,650.00
9/13/2021	Bradford Crutchfield	Insider	Sell	17,000	$174.49	$2,966,330.00	60,336
9/7/2021	Serge Saxonov	CEO	Sell	15,000	$188.42	$2,826,300.00
9/1/2021	Benjamin J. Hindson	Insider	Sell	41,666	$177.50	$7,395,715.00
9/1/2021	John R. Stuelpnagel	Director	Sell	5,000	$177.48	$887,400.00
9/1/2021	Justin J Mcanear	CFO	Sell	10,000	$177.49	$1,774,900.00
8/23/2021	Benjamin J. Hindson	Insider	Sell	337	$161.85	$54,543.45	47,117
8/23/2021	Justin J. McAnear	CFO	Sell	270	$161.85	$43,699.50	43,336
8/23/2021	Serge Saxonov	CEO	Sell	742	$161.85	$120,092.70
8/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$162.06	$243,090.00	3,458
8/16/2021	John R. Stuelpnagel	Director	Sell	5,000	$159.56	$797,800.00	386,313
7/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$183.67	$275,505.00
7/16/2021	John R. Stuelpnagel	Director	Sell	5,000	$170.31	$851,550.00	396,116
7/12/2021	Bradford Crutchfield	Insider	Sell	17,000	$186.53	$3,171,010.00
7/6/2021	Serge Saxonov	CEO	Sell	15,000	$193.08	$2,896,200.00
6/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$199.95	$299,925.00	3,458
6/17/2021	John R. Stuelpnagel	Director	Sell	5,000	$199.38	$996,900.00	406,516
6/14/2021	Bradford Crutchfield	Insider	Sell	17,000	$191.69	$3,258,730.00	60,262
6/8/2021	Serge Saxonov	CEO	Sell	15,000	$186.37	$2,795,550.00	904,068
5/24/2021	Benjamin J. Hindson	Insider	Sell	351	$162.66	$57,093.66
5/24/2021	Justin J. McAnear	CFO	Sell	281	$162.66	$45,707.46
5/24/2021	Serge Saxonov	CEO	Sell	771	$162.66	$125,410.86
5/24/2021	Sridhar Kosaraju	Director	Sell	1,500	$161.16	$241,740.00	2,833
5/17/2021	John R. Stuelpnagel	Director	Sell	7,500	$141.57	$1,061,775.00	420,491
5/12/2021	Bradford Crutchfield	Insider	Sell	17,000	$134.78	$2,291,260.00	51,608
5/4/2021	Serge Saxonov	CEO	Sell	15,000	$184.08	$2,761,200.00	885,676
5/3/2021	Benjamin J. Hindson	Insider	Sell	41,666	$191.84	$7,993,205.44	60,716
5/3/2021	John R. Stuelpnagel	Director	Sell	7,500	$191.81	$1,438,575.00	427,891
5/3/2021	Justin J Mcanear	CFO	Sell	10,000	$191.93	$1,919,300.00	40,357
4/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$193.08	$289,620.00
4/16/2021	John R. Stuelpnagel	Director	Sell	7,500	$192.61	$1,444,575.00	434,891
4/12/2021	Bradford Crutchfield	Insider	Sell	17,000	$185.89	$3,160,130.00	51,608
4/6/2021	Serge Saxonov	CEO	Sell	15,000	$195.81	$2,937,150.00	885,676
4/1/2021	Benjamin J. Hindson	Insider	Sell	41,666	$184.54	$7,689,043.64	78,302
4/1/2021	John R. Stuelpnagel	Director	Sell	7,500	$184.53	$1,383,975.00	443,250
4/1/2021	Justin J Mcanear	CFO	Sell	10,000	$184.52	$1,845,200.00	40,357
3/23/2021	Sridhar Kosaraju	Director	Sell	1,500	$174.63	$261,945.00	2,833
3/17/2021	John R. Stuelpnagel	Director	Sell	7,500	$169.36	$1,270,200.00	450,291
3/8/2021	Justin J Mcanear	CFO	Sell	10,000	$147.30	$1,473,000.00	30,774
2/16/2021	John R. Stuelpnagel	Director	Sell	7,500	$193.00	$1,447,500.00	465,591
2/1/2021	Benjamin J. Hindson	Insider	Sell	33,750	$175.98	$5,939,325.00	69,686
2/1/2021	John R. Stuelpnagel	Director	Sell	7,500	$176.05	$1,320,375.00	473,091
2/1/2021	Serge Saxonov	CEO	Sell	10,000	$176.00	$1,760,000.00	889,576
1/19/2021	John R. Stuelpnagel	Director	Sell	7,500	$178.76	$1,340,700.00	479,591
1/4/2021	Benjamin J. Hindson	Insider	Sell	33,750	$139.93	$4,722,637.50	100,437
1/4/2021	John R. Stuelpnagel	Director	Sell	7,500	$139.86	$1,048,950.00	487,191
1/4/2021	Serge Saxonov	CEO	Sell	10,000	$139.93	$1,399,300.00	890,468
12/16/2020	John R. Stuelpnagel	Director	Sell	7,500	$148.21	$1,111,575.00	494,890
12/1/2020	Benjamin J. Hindson	Insider	Sell	33,750	$151.32	$5,107,050.00	101,250
12/1/2020	John R. Stuelpnagel	Director	Sell	7,500	$151.23	$1,134,225.00	501,391
12/1/2020	Serge Saxonov	CEO	Sell	10,000	$151.40	$1,514,000.00	973,431
11/17/2020	John R. Stuelpnagel	Director	Sell	7,500	$135.98	$1,019,850.00	510,591
11/2/2020	Benjamin J. Hindson	Insider	Sell	21,062	$136.38	$2,872,435.56	88,562
11/2/2020	John R. Stuelpnagel	Director	Sell	7,500	$136.36	$1,022,700.00	516,163
11/2/2020	Justin J Mcanear	CFO	Sell	7,100	$136.35	$968,085.00	8,033
11/2/2020	Serge Saxonov	CEO	Sell	7,076	$136.35	$964,812.60	973,431
10/16/2020	John R. Stuelpnagel	Director	Sell	7,500	$164.26	$1,231,950.00	521,492
9/16/2020	John R. Stuelpnagel	Director	Sell	7,500	$121.63	$912,225.00	540,591
9/1/2020	Benjamin J. Hindson	Insider	Sell	27,692	$113.97	$3,156,057.24	95,192
9/1/2020	John R. Stuelpnagel	Director	Sell	7,500	$113.92	$854,400.00	546,489
9/1/2020	Serge Saxonov	CEO	Sell	10,000	$113.97	$1,139,700.00	955,821
8/17/2020	John R. Stuelpnagel	Director	Sell	7,500	$104.67	$785,025.00	555,191
8/3/2020	Benjamin J. Hindson	Insider	Sell	33,750	$99.34	$3,352,725.00	101,250
8/3/2020	John R. Stuelpnagel	Director	Sell	7,500	$99.34	$745,050.00	558,823
8/3/2020	Serge Saxonov	CEO	Sell	10,000	$99.33	$993,300.00	963,181
7/16/2020	John R. Stuelpnagel	Director	Sell	7,500	$88.86	$666,450.00	567,217
7/1/2020	Benjamin J. Hindson	Insider	Sell	33,750	$87.60	$2,956,500.00	101,250
7/1/2020	John R. Stuelpnagel	Director	Sell	7,500	$87.58	$656,850.00	574,987
7/1/2020	Serge Saxonov	CEO	Sell	10,000	$87.58	$875,800.00	963,181
6/17/2020	John R. Stuelpnagel	Director	Sell	7,500	$89.14	$668,550.00	582,196
6/1/2020	Benjamin J. Hindson	Insider	Sell	33,750	$79.85	$2,694,937.50	101,250
6/1/2020	Serge Saxonov	CEO	Sell	10,000	$79.82	$798,200.00	963,181
5/20/2020	Associates Vi L.P. Venrock	Major Shareholder	Sell	1,013,569	$78.00	$79,058,382.00
5/20/2020	Bryan E Roberts	Director	Sell	3,100,000	$78.00	$241,800,000.00
5/13/2020	Foresite Capital Management I,	Major Shareholder	Sell	1,450,000	$80.13	$116,188,500.00
5/1/2020	Benjamin J. Hindson	Insider	Sell	33,750	$77.38	$2,611,575.00	101,250
5/1/2020	Serge Saxonov	CEO	Sell	10,000	$77.39	$773,900.00	955,514
4/1/2020	Benjamin J. Hindson	Insider	Sell	33,750	$58.12	$1,961,550.00	101,250
4/1/2020	Serge Saxonov	CEO	Sell	10,000	$58.07	$580,700.00	960,514
3/17/2020	Foresite Capital Management I,	Major Shareholder	Sell	750,000	$59.00	$44,250,000.00
3/6/2020	Benjamin J. Hindson	Insider	Sell	33,750	$65.59	$2,213,662.50	101,250
3/6/2020	Serge Saxonov	CEO	Sell	10,000	$65.14	$651,400.00	946,347
9/16/2019	Bryan E Roberts	Director	Buy	300,000	$39.00	$11,700,000.00
9/13/2019	Bryan E Roberts	Director	Buy	30,000	$23.31	$699,300.00
9/12/2019	Foresite Capital Fund I, L.P.	Major Shareholder	Buy	187,500	$39.00	$7,312,500.00

"new normal coming"???

From Legacy Research | Ad

PhD who walked away from her million-dollar career at Goldman Sachs says "Strange new normal coming"

Learn more.

SEC Filings (Institutional Ownership Changes) for 10x Genomics (NASDAQ:TXG)

76.25% of 10x Genomics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

10x Genomics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/13/2022	Renaissance Technologies LLC	57,800	$4.40M	0.0%	+224.7%	0.051%
5/13/2022	Evolutionary Tree Capital Management LLC	54,128	$4.12M	2.9%	N/A	0.048%
5/13/2022	Bellevue Group AG	252,859	$19.24M	0.2%	+8.7%	0.224%
5/13/2022	Northern Trust Corp	474,719	$36.11M	0.0%	+1.1%	0.421%
5/13/2022	Brandywine Managers LLC	8,241	$0.63M	1.1%	+14.2%	0.007%
5/13/2022	Charles Schwab Investment Management Inc.	502,270	$38.21M	0.0%	+2.0%	0.445%
5/13/2022	Lazard Asset Management LLC	69,784	$5.31M	0.0%	+31.1%	0.062%
5/13/2022	Utah Retirement Systems	17,020	$1.30M	0.0%	+12.5%	0.015%
5/13/2022	Employees Retirement System of Texas	24,000	$1.83M	0.0%	+84.6%	0.021%
5/13/2022	AlpInvest Partners B.V.	6,380	$0.49M	0.2%	+150.0%	0.006%
5/13/2022	Clearbridge Investments LLC	1,440,875	$109.61M	0.1%	+28.8%	1.277%
5/13/2022	Jasper Ridge Partners L.P.	28,923	$2.20M	0.1%	+12.9%	0.026%
5/13/2022	First Trust Advisors LP	36,101	$2.75M	0.0%	-67.7%	0.032%
5/13/2022	USS Investment Management Ltd	27,666	$2.11M	0.0%	+71.2%	0.025%
5/13/2022	Bridgewater Associates LP	6,182	$0.47M	0.0%	N/A	0.005%
5/13/2022	Pier 88 Investment Partners LLC	2,340	$0.18M	0.1%	-52.5%	0.002%
5/13/2022	Sands Capital Management LLC	3,201,394	$243.53M	0.6%	+92.4%	2.837%
5/13/2022	Mackenzie Financial Corp	4,191	$0.32M	0.0%	-73.3%	0.004%
5/13/2022	Candriam Luxembourg S.C.A.	5,182	$0.39M	0.0%	+19.6%	0.005%
5/13/2022	Vanguard Group Inc.	7,732,523	$588.21M	0.0%	+2.4%	6.852%
5/13/2022	Sei Investments Co.	28,948	$2.20M	0.0%	+39.1%	0.026%
5/13/2022	Lord Abbett & CO. LLC	59,159	$4.50M	0.0%	-30.9%	0.052%
5/13/2022	Vontobel Holding Ltd.	16,594	$1.24M	0.0%	+74.1%	0.015%
5/13/2022	Dimensional Fund Advisors LP	77,728	$5.91M	0.0%	+17.8%	0.069%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	12,016	$0.91M	0.0%	-11.1%	0.011%
5/12/2022	Citizens Financial Group Inc RI	4,120	$0.31M	0.0%	+31.8%	0.004%
5/12/2022	Great West Life Assurance Co. Can	62,634	$5.04M	0.0%	+3.6%	0.056%
5/12/2022	APG Asset Management N.V.	18,497	$1.27M	0.0%	-3.0%	0.016%
5/12/2022	BlackRock Inc.	9,156,992	$696.57M	0.0%	+14.2%	8.115%
5/12/2022	Quent Capital LLC	4,840	$0.37M	0.1%	+2,869.3%	0.004%
5/12/2022	Rhumbline Advisers	71,177	$5.41M	0.0%	-9.6%	0.063%
5/12/2022	MetLife Investment Management LLC	5,470	$0.42M	0.0%	N/A	0.005%
5/12/2022	Northeast Financial Consultants Inc	2,691	$0.21M	0.0%	+46.4%	0.002%
5/12/2022	Renaissance Capital LLC	26,526	$2.02M	0.9%	-23.0%	0.024%
5/12/2022	Bank of Montreal Can	3,890	$0.29M	0.0%	-88.4%	0.003%
5/12/2022	Pitcairn Co.	3,854	$0.29M	0.0%	+180.5%	0.003%
5/12/2022	PNC Financial Services Group Inc.	2,046	$0.16M	0.0%	+617.9%	0.002%
5/12/2022	Mitsubishi UFJ Trust & Banking Corp	224,744	$17.10M	0.0%	+0.4%	0.199%
5/12/2022	Oppenheimer Asset Management Inc.	2,700	$0.21M	0.0%	+91.8%	0.002%
5/12/2022	Oppenheimer & Co. Inc.	7,803	$0.59M	0.0%	N/A	0.007%
5/11/2022	US Bancorp DE	9,711	$0.74M	0.0%	+39.6%	0.009%
5/11/2022	American Century Companies Inc.	118,751	$9.03M	0.0%	-84.0%	0.105%
5/11/2022	Bank of New York Mellon Corp	834,100	$63.45M	0.0%	+11.7%	0.739%
5/11/2022	Granite Point Capital Management L.P.	6,000	$0.46M	0.1%	N/A	0.005%
5/11/2022	Handelsbanken Fonder AB	13,082	$1M	0.0%	+7.4%	0.012%
5/11/2022	Raymond James & Associates	53,009	$4.03M	0.0%	+19.3%	0.047%
5/11/2022	NN Investment Partners Holdings N.V.	21,880	$1.67M	0.0%	+5.2%	0.019%
5/11/2022	JPMorgan Chase & Co.	83,761	$6.37M	0.0%	-43.2%	0.074%
5/10/2022	Profund Advisors LLC	11,410	$0.87M	0.0%	-9.4%	0.010%
5/10/2022	TD Asset Management Inc.	62,533	$4.76M	0.0%	+4.2%	0.055%
5/10/2022	Van ECK Associates Corp	79,055	$6.01M	0.0%	+26.1%	0.070%
5/10/2022	Steel Peak Wealth Management LLC	8,809	$0.67M	0.0%	N/A	0.008%
5/10/2022	Decheng Capital Management III Cayman LLC	303,984	$23.12M	7.1%	N/A	0.269%
5/10/2022	NewEdge Wealth LLC	4,382	$0.33M	0.0%	+110.5%	0.004%
5/10/2022	Capricorn Fund Managers Ltd	25,000	$1.90M	0.5%	N/A	0.022%
5/10/2022	Elo Mutual Pension Insurance Co	14,496	$1.10M	0.0%	N/A	0.013%
5/10/2022	Treasurer of the State of North Carolina	31,144	$2.37M	0.0%	-41.7%	0.028%
5/9/2022	Toronto Dominion Bank	15,813	$1.20M	0.0%	+10.9%	0.014%
5/9/2022	Principal Financial Group Inc.	20,625	$1.57M	0.0%	-5.6%	0.018%
5/9/2022	Swiss National Bank	337,224	$25.65M	0.0%	+15.2%	0.299%
5/9/2022	Teacher Retirement System of Texas	15,948	$1.21M	0.0%	+4.5%	0.014%
5/9/2022	Forsta AP Fonden	18,900	$1.44M	0.0%	N/A	0.017%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	17,941	$1.37M	0.0%	-2.6%	0.016%
5/9/2022	M&T Bank Corp	2,916	$0.22M	0.0%	+41.8%	0.003%
5/6/2022	State Board of Administration of Florida Retirement System	96,225	$7.32M	0.0%	+4.0%	0.085%
5/6/2022	AIA Group Ltd	15,160	$1.15M	0.1%	-51.6%	0.013%
5/6/2022	Nikko Asset Management Americas Inc.	1,431,773	$108.92M	0.8%	+14.7%	1.269%
5/6/2022	IFM Investors Pty Ltd	11,549	$0.88M	0.0%	+19.9%	0.010%
5/6/2022	Mirador Capital Partners LP	21,947	$1.67M	0.3%	+2.2%	0.019%
5/5/2022	Baillie Gifford & Co.	7,355,764	$559.55M	0.4%	+6.9%	6.518%
5/5/2022	New York State Common Retirement Fund	296,321	$22.54M	0.0%	+24.8%	0.263%
5/5/2022	Russell Investments Group Ltd.	378,757	$28.81M	0.1%	+52.4%	0.336%
5/4/2022	California Public Employees Retirement System	160,300	$12.19M	0.0%	-3.0%	0.142%
5/4/2022	Advisor Group Holdings Inc.	12,862	$0.92M	0.0%	-4.1%	0.011%
5/4/2022	Pictet & Cie Europe SA	4,234	$0.32M	0.0%	+11.2%	0.004%
5/4/2022	Banque Pictet & Cie SA	60,570	$4.61M	0.0%	-8.4%	0.054%
5/4/2022	Envestnet Asset Management Inc.	13,864	$1.06M	0.0%	-8.4%	0.012%
5/4/2022	Arizona State Retirement System	21,670	$1.65M	0.0%	+3.3%	0.019%
5/3/2022	Column Capital Advisors LLC	1,182	$90K	0.0%	+28.8%	0.001%
5/3/2022	State of New Jersey Common Pension Fund D	49,823	$3.79M	0.0%	+6.9%	0.044%
5/3/2022	FDx Advisors Inc.	4,463	$0.34M	0.0%	+45.9%	0.004%
5/2/2022	Slow Capital Inc.	41,790	$3.18M	0.6%	+143.0%	0.037%
4/29/2022	SG Americas Securities LLC	3,201	$0.24M	0.0%	N/A	0.003%
4/29/2022	Nisa Investment Advisors LLC	3,800	$0.29M	0.0%	N/A	0.003%
4/29/2022	North Star Asset Management Inc.	40,303	$3.07M	0.2%	+16.3%	0.036%
4/28/2022	Parallel Advisors LLC	20,234	$1.51M	0.1%	+172.5%	0.018%
4/28/2022	DekaBank Deutsche Girozentrale	40,687	$3.13M	0.0%	+27.0%	0.036%
4/27/2022	Vestmark Advisory Solutions Inc.	10,666	$0.81M	0.0%	+90.6%	0.009%
4/27/2022	Sumitomo Mitsui Trust Holdings Inc.	1,618,353	$123.11M	0.1%	+12.8%	1.434%
4/26/2022	Ieq Capital LLC	68,658	$5.22M	0.1%	+47.3%	0.061%
4/25/2022	Cerity Partners LLC	16,483	$1.25M	0.0%	+727.5%	0.015%
4/25/2022	China Universal Asset Management Co. Ltd.	9,359	$0.71M	0.3%	-51.0%	0.008%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	15,051	$1.15M	0.0%	+13.0%	0.013%
4/21/2022	CWM LLC	7,212	$0.55M	0.0%	-12.0%	0.006%
4/20/2022	Koshinski Asset Management Inc.	536	$41K	0.0%	+46.4%	0.000%
4/19/2022	Green Alpha Advisors LLC	8,001	$0.61M	0.4%	+15.1%	0.007%
4/19/2022	ARK Investment Management LLC	3,391,338	$257.98M	1.1%	+27.5%	3.005%
4/16/2022	IFM Investors Pty Ltd	11,549	$0.88M	0.0%	+19.9%	0.010%
4/13/2022	Redpoint Investment Management Pty Ltd	3,424	$0.26M	0.0%	N/A	0.003%
4/12/2022	Stonnington Group LLC	10,000	$0.73M	0.2%	N/A	0.009%

Data available starting January 2016

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Today's Range

Now: $47.63

$42.37

$47.67

50 Day Range

MA: $62.38

$39.65

$82.41

52 Week Range

Now: $47.63

$36.76

$208.99

Volume

2,413,500 shs

Average Volume

1,389,841 shs

Market Capitalization

$5.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92

Who are the company insiders with the largest holdings of 10x Genomics?: 10x Genomics' top insider investors include:
Serge Saxonov (CEO)
John R Stuelpnagel (Director)
John R Stuelpnagel (Director)
Benjamin J Hindson (Insider)
Bradford Crutchfield (Insider)
Justin J Mcanear (CFO)
Justin J Mcanear (CFO)
Sridhar Kosaraju (Director)
Associates Vi LP Venrock (Major Shareholder)
Benjamin J Hindson (Insider)
Bryan E Roberts (Director)
Learn More about top insider investors at 10x Genomics.
Who are the major institutional investors of 10x Genomics?: 10x Genomics' top institutional shareholders include:
BlackRock Inc. — 8.11%
Vanguard Group Inc. — 6.85%
Baillie Gifford & Co. — 6.52%
ARK Investment Management LLC — 3.01%
Sands Capital Management LLC — 2.84%
Sumitomo Mitsui Trust Holdings Inc. — 1.43%
Learn More about top institutional investors of 10x Genomics stock.
Which institutional investors are selling 10x Genomics stock?: Within the previous quarter, TXG stock was sold by these institutional investors:
American Century Companies Inc.
First Trust Advisors LP
JPMorgan Chase & Co.
Bank of Montreal Can
Lord Abbett & CO. LLC
Treasurer of the State of North Carolina
AIA Group Ltd
Mackenzie Financial Corp
Within the previous year, company insiders that have sold 10x Genomics company stock include:
Serge Saxonov (CEO)
John R Stuelpnagel (Director)
John R Stuelpnagel (Director)
Benjamin J Hindson (Insider)
Bradford Crutchfield (Insider)
Justin J Mcanear (CFO)
Justin J Mcanear (CFO)
Sridhar Kosaraju (Director)
Associates Vi LP Venrock (Major Shareholder)
Learn More investors selling 10x Genomics stock.
Which institutional investors are buying 10x Genomics stock?: In the previous quarter, TXG stock was bought by institutional investors including:
Sands Capital Management LLC
BlackRock Inc.
ARK Investment Management LLC
Baillie Gifford & Co.
Clearbridge Investments LLC
Decheng Capital Management III Cayman LLC
Sumitomo Mitsui Trust Holdings Inc.
Nikko Asset Management Americas Inc.

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.